Clinical

Weekly Digest – September 2024 Weekly Digest – September 2024 18 Sep 2024: Daiichi Sankyo-Merck’s ‘guided-missile’ cancer drug meets main goal in late-stage trial Daiichi Sankyo and Merck announced that Patritumab Deruxtecan successfully extended progression-free survival in a late-stage study […]

by Sandhya Ramalingam

Continue Reading

Weekly Digest – September 2024 Weekly Digest – September 2024 18 Sep 2024: Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference Zymeworks will present preclinical data for their antibody-drug conjugate (ADC) candidates ZW220 and ZW251 at […]

by Sandhya Ramalingam

Continue Reading